22 phd-in-architecture-landscape-built-environment PhD positions at University of Cambridge in Uk
-
is characterizing the solid-state landscape of drug candidates, which can involve complex solid-phase transitions such as the dehydration of hydrates, desolvation of solvates, and solid-solid phase
-
metabolomics, as well as imaging mass cytometry, and test the effect of AZ clinical compounds on the immune-metabolic landscape of our PanIN-to-PDAC models. Dr Koulman will provide training and support with
-
PhD studentship: Defining the role of the pioneer factor FOXA1 in hormone-dependent cancer Supervisor: Professor Jason Carroll Course start date: 1st October 2026 Project details For further
-
We invite applications from creative and motivated individuals to join Professor Sir Shankar Balasubramanian's group for a 4-year PhD studentship, working on a multidisciplinary project exploiting
-
of the chromatin landscape in prostate cancer. Nat Commun. 2022 Apr 27;13(1):2282 https://pubmed.ncbi.nlm.nih.gov/35477723/ Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer
-
@ch.cam.ac.uk , including 'PhD CI ¿ October 2026' in the subject. How to apply Please apply via the University Applicant Portal. For further information about the course and to access the Applicant Portal, click
-
Supervisors: Professor Greg Hannon and Dr Ben Nicholson For further information about the research group, including their most recent publications, please visit their websites: https://www.cruk.cam.ac.uk/research-groups/hannon-group and http://www.hannonlab.org/ Overview We are looking for a...
-
Supervisor: Professor Florian Markowetz Course start date: 1st Oct 2026 Overview Professor Florian Markowetz wishes to recruit a student to work on the project entitled: “Development and application of computational tools for the early detection and deconstruction of chromosomal instability in...
-
laboratory mice throughout the PhD is an essential requirement. Funding This four-year studentship includes full funding for University fees and an index-linked stipend starting at £22,500 for four years
-
Supervisors: Professor Sir Steve Jackson and Dr Mark O'Connor (AZ Partner) Course start date: 1st October 2026 Project details Targeted Alpha Therapy (TAT) selectively delivers high Linear Energy Transfer (LET) alpha-particles to cancer cells, maximising efficacy while minimising toxicity. ...